News Nov 16, 2016 Circulation Research, a Journal of the American Heart Association Results from CardioCell’s Phase IIa chronic heart failure clinical trial are featured in a peer-reviewed article now available in the American Heart Association's journal Circulation Research.
Read More
Intravenous Cardiac Stem Cell Therapy Offers Clinical Benefits
News Oct 13, 2016 Intravenous Cardiac Stem Cell Therapy Offers Clinical Benefits Cultured stem cells have, for the first time, been used to treat non-ischaemic cardiomyopathy patients non-invasively, resulting in significantly improved measures of health status. READ FULL ARTICLE
Read MoreIndependent Data Safety Monitoring Board (DSMB) Unanimously Recommends CardioCell’s Heart Failure Studies Continue
News Oct 12, 2016 Independent Data Safety Monitoring Board (DSMB) Unanimously Recommends CardioCell’s Heart Failure Studies Continue SAN DIEGO – Oct. 12, 2016 – CardioCell LLC, a global biotechnology company that uses allogeneic stem cells for cardiovascular indications, announces an
Read More
AHA Scientific Sessions 2016
Events AHA Scientific Sessions 2016 Nov. 12-16 New Orleans, LA
Read More
VIDEO: An interview with Dr Javed Butler at the 2016 ESC Congress
News Sep 27, 2016 VIDEO: An interview with Dr Javed Butler at the 2016 ESC Congress An interview with Dr Javed Butler (Chief of the Cardiology Division, Stony Brook University) at the 2016 European Society of Cardiology Congress, Rome, Italy. VIEW VIDEO HERE
Read More
VIDEOS: European Society of Cardiology Congress 2016
News Sep 8, 2016 VIDEOS: European Society of Cardiology Congress 2016 In a series of videos, Dr. Javed Butler shares details from his ESC Congress Hot Line presentation and news and views about the conference. VIEW VIDEOS HERE
Read More
CardioCell LLC Retains Objective Capital Partners
News Sep 7, 2016 CardioCell LLC Retains Objective Capital Partners San Diego biotech CardioCell LLC has retained Objective Capital Partners, an investment bank and mergers and acquisitions advisory firm, to help the company “manage growth,” the company said in a
Read MoreObjective Capital Partners Adds CardioCell to Expanding Portfolio of Life Science Companies
News Sep 7, 2016 Objective Capital Partners Adds CardioCell to Expanding Portfolio of Life Science Companies SAN DIEGO – Sept. 7, 2016 – Objective Capital Partners, a leading middle market investment bank and mergers and acquisition (M&A) advisory firm focused on transactions for
Read More